Real cancer slides, trained through closed hospital firewalls
Despite a broad range of potential side effects, the efficacy of Ozempic in regulating blood sugar levels in type 2 diabetes patients has been well-documented
In December 2024, the FDA issued warning letters to several companies selling peptide products online, citing compounds such as retatrutide along with semaglutide and tirzepatide being marketed under research use only disclaimers while appearing to target consumers seeking weight-loss or performance benefits
So this is a nice option. END
Weight Loss Use and Age Considerations Beyond FDA Label Ozempic is not FDA-approved for weight loss in any age group, though similar compounds like Wegovy (semaglutide) carry explicit weight management approval for adults 18 and older
However, it is not FDA-approved for any specific indication